Kristine Hue van
Optometrist · Richmond, VANPI 1457504821
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,026 of the $7,727 with a category attached, or 78.0%. 20 manufacturers reported payments, led by Johnson & Johnson Vision Care, Inc. at 25.3% of the total. Among optometrist clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 133 payments — averaging $58.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$2K
- Bausch & Lomb Americas Inc.$1K
- Johnson & Johnson Surgical Vision, Inc.$821
- Bausch & Lomb, A Division Of Bausch Health US, LLC$791
- Alcon$718
- Coopervision Inc.$421
- plus $2K from 14 others
What the payments were for
- Consulting fees$98313%
- Travel & lodging$6108%
- Food & beverage$6,02678%
- Gifts$170%
- Entertainment$911%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 27 | $1,958 |
| Bausch & Lomb Americas Inc. | 23 | $1,275 |
| Johnson & Johnson Surgical Vision, Inc. | 7 | $821 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 12 | $791 |
| Alcon | 23 | $718 |
| Coopervision Inc. | 12 | $421 |
| Biotissue Holdings Inc. | 6 | $372 |
| Sun Pharmaceutical Industries Inc. | 5 | $293 |
| Dompe US, Inc. | 2 | $236 |
| AbbVie(2 entities) | 2 | $214 |
| Quidel Corporation | 1 | $114 |
| LKC Technologies, Inc. | 1 | $110 |
| Optos, Inc. | 1 | $91 |
| Maculogix, Inc. | 1 | $76 |
| Oasis Medical, Inc. | 3 | $72 |
| Shire North American Group Inc | 1 | $66 |
| Sight Sciences, Inc. | 2 | $36 |
| ABB Con-cise Optical Group LLC | 2 | $28 |
| Oyster Point Pharma, Inc. | 1 | $19 |
| Carl Zeiss Meditec, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acuvue$1,344
- TearScience Lipiflow System$610
- TearScience Lipiview System$610
- TearScience Lipiscan System$610
- ULTRA$354
- BIOTRUE ONE DAY$244
- MIEBO$240
- XIIDRA$240
- Oxervate$236
- INFUSE$230
- Precision7$131
- BIOTRUE$125
- CEQUA$125
- TOTAL30$122
- Precision 1$122
- DAILIES TOTAL1$122
- DURYSTA$122
- Prokera$114
- AmnioGraft$114
- Eye Health$114
How this compares
$7,727 in reported general payments places this provider in the 95th percentile of 1,230 optometrist providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MieboPerfluorohexyloctane/Pf | 37 | $33,718 |
| RestasisCyclosporine | 20 | $17,068 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb Americas Inc.Miebo | $1,275 | $33,71837 claims |
| AbbVieRestasis | $214 | $17,06820 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,230 optometrist providers in Virginia.
Other optometrist in Richmond
- Jacqueline TheisRichmond$80K
- Joseph AllenRichmond$75K
- Jeffrey FardinkRichmond$23K
- Raquel MoncrieffeRichmond$18K
- Gerald NeidighRichmond$15K
- Eric NilsenRichmond$11K
- Charline AnselmeRichmond$6K
- Walter WhitleyNorfolk$546K
- Keith SmithsonReston$74K
- Michael SwattsChesapeake$59K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.